These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35167511)

  • 1. Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy.
    Futai R; Yoshie T; Sanuki T; Inoue Y; Abe T; Sasaki A; Iemoto T; Hayashi H; Ose T; Morikawa T
    Am J Case Rep; 2022 Feb; 23():e935121. PubMed ID: 35167511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Syndrome of inappropriate antidiuretic hormone secretion following adjuvant CDDP and 5-FU administration in a patient with esophageal carcinoma].
    Horio T; Tsujimoto H; Akase T; Sakamoto N; Yaguchi Y; Hiraki S; Aiko S; Takechi H; Hase K; Maehara T
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1945-8. PubMed ID: 20948261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of consciousness disorder induced by the syndrome of inappropriate secretion of antidiuretic hormone following cisplatin and 5-fluorouracil chemotherapy in a patient with esophageal cancer].
    Endo C; Takagawa R; Chiba T; Kawamoto M; Konishi T; Honma Y; Minami Y; Watanabe J; Morita T; Mogaki M; Masui H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2130-2. PubMed ID: 24394036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of syndrome of inappropriate antidiuretic hormone secretion in a patient with esophageal carcinoma possibly induced by cisplatin in neoadjuvant chemotherapy].
    Sawano T; Kawasaki H; Wajima N; Miyamoto K; Ishizawa Y; Nakai M; Hakamada K
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):999-1003. PubMed ID: 25132033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of SIADH developed during neoadjuvant chemotherapy using nedaplatin and 5-fluorouracil in a patient with esophageal cancer].
    Matsuda Y; Lee S; Kishida S; Mori K; Isohata N; Iwasaki H; Hashiba R; Gyobu K; Osugi H
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1787-90. PubMed ID: 20841948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin.
    Kadono T; Yamamoto S; Hirose T; Ikeda G; Ohara A; Itoyama M; Yokoyama K; Honma Y; Hashimoto T; Sekine S; Ishiyama K; Oguma J; Daiko H; Kato K
    Esophagus; 2023 Jan; 20(1):109-115. PubMed ID: 36050607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.
    Messager M; Mirabel X; Tresch E; Paumier A; Vendrely V; Dahan L; Glehen O; Vasseur F; Lacornerie T; Piessen G; El Hajbi F; Robb WB; Clisant S; Kramar A; Mariette C; Adenis A
    BMC Cancer; 2016 May; 16():318. PubMed ID: 27194176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Case of Consciousness Disorder Induced by the Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Cisplatin and 5-Fluorouracil Chemotherapy in a Patient with Tongue Cancer].
    Tamura T; Taniguchi N; Otsuki K; Narai T; Kawasaki M; Fujii N; Doi R; Kodani I
    Gan To Kagaku Ryoho; 2018 May; 45(5):855-857. PubMed ID: 30026451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
    Reynolds JV; Preston SR; O'Neill B; Lowery MA; Baeksgaard L; Crosby T; Cunningham M; Cuffe S; Griffiths GO; Parker I; Risumlund SL; Roy R; Falk S; Hanna GB; Bartlett FR; Alvarez-Iglesias A; Achiam MP; Nilsson M; Piessen G; Ravi N; O'Toole D; Johnston C; McDermott RS; Turkington RC; Wahed S; Sothi S; Ford H; Wadley MS; Power D;
    Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):1015-1027. PubMed ID: 37734399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified FOLFOX-6 therapy for heavily pretreated advanced gastric cancer refractory to fluorouracil, irinotecan, cisplatin and taxanes: a retrospective study.
    Tsuji K; Yasui H; Onozawa Y; Boku N; Doyama H; Fukutomi A; Yamazaki K; Machida N; Todaka A; Taniguchi H; Tsushima T; Yokota T
    Jpn J Clin Oncol; 2012 Aug; 42(8):686-90. PubMed ID: 22693245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe Hyponatremia after Cisplatin-Based Chemotherapy : Two Case Reports].
    Ohtaka M; Hattori Y; Kumano Y; Maeda Y; Kondo T; Mochizuki T; Kawahara T; Teranishi J; Miyoshi Y; Yumura Y; Uemura H
    Hinyokika Kiyo; 2016 Jul; 62(7):361-6. PubMed ID: 27569354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis.
    Nishiwaki N; Noma K; Kunitomo T; Hashimoto M; Maeda N; Tanabe S; Sakurama K; Shirakawa Y; Fujiwara T
    Esophagus; 2022 Oct; 19(4):626-638. PubMed ID: 35792947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial).
    Goto H; Oshikiri T; Kato T; Nagatani Y; Funakoshi Y; Koterazawa Y; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Minami H; Kakeji Y
    PLoS One; 2024; 19(4):e0299742. PubMed ID: 38635652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of renal salt wasting syndrome progressing to severe hyponatremia after gemcitabine-cisplatin chemotherapy].
    Matsumura E; Oshiro Y; Miyagi R; Kimura R; Ashimine S; Machida N; Miyazato M; Saito S
    Hinyokika Kiyo; 2012 Aug; 58(8):425-9. PubMed ID: 23052267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal small-cell carcinoma with syndrome of inappropriate secretion of antidiuretic hormone.
    Ando T; Hosokawa A; Yamawaki H; Hasumoto Y; Kajiura S; Itaya Y; Ueda A; Suzuki N; Nishikawa J; Fujinami H; Miyazaki T; Ogawa K; Sugiyama T
    Intern Med; 2011; 50(10):1099-103. PubMed ID: 21576835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Syndrome of inappropriate secretion of ADH following chemoradiation therapy].
    Kikuchi N; Masuda M; Tamura T; Nakazawa K; Kanemoto K; Iijima H; Ishikawa H; Sato S; Ishii Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1711-4. PubMed ID: 23152025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
    Culy CR; Clemett D; Wiseman LR
    Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia in patients with esophageal cancer treated with chemotherapy including cisplatin.
    Shimada A; Takeuchi H; Fukuda K; Suda K; Nakamura R; Wada N; Kawakubo H; Kitagawa Y
    Esophagus; 2018 Oct; 15(4):209-216. PubMed ID: 30225740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.